Despite the existing research on the roles of CDC20 and CCNB1 in cell cycle regulation, there remains a lack of comprehensive studies specifically linking their expression levels to clinical outcomes in BC, highlighting the need for further investigation to clarify their potential as biomarkers for treatment response and early diagnosis. Here, CDC20 is linked to breast cancer.